Welcome to the first edition of the President’s Corner! I am grateful to Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS, and the editors of The Rheumatologist for their support and encouragement in allowing me to have this opportunity each month to come together with rheumatologists and rheumatology health professionals. So why the President’s Corner? In…
At a busy and highly successful interim meeting of the AMA House of Delegates, an ACR-cosponsored resolution that calls for exceptions to therapy caps was passed and will become AMA policy. Other areas addressed include payment parity for telemedicine and MIPS reform.
The diversity of the ARP’s membership is what originally drew Adam Goode, PT, DPT, PhD, to the organization, enticed him to begin volunteering more than a decade ago and now galvanizes him as he becomes the new ARP president.
The position refers to relevant ACR clinical guidelines and supports continued research and innovative methods for evaluating these modalities in clinical practice.
With a likely Republican majority in the House and Senate and a Republican president, there may be a sense that the party has a mandate to lead initiatives and enact significant policy changes. Any end-of-year legislative package will be narrower than initially expected, but the ACR’s top priority remains addressing cuts to physician reimbursements.
The Alliance for Transparent and Affordable Prescriptions’ board members for the 2024–25 cycle include Marcus Snow, MD, and Howard Blumstein, MD, who both have a strong history of volunteer leadership in the ACR.
“While our group carefully considered your application, I regret to inform you that you were not selected this year to serve as a committee volunteer.” When the email arrived, gently delivering the news that my application to volunteer with the ACR on a committee had not been accepted, my initial reaction was to dismiss it…
The ACR’s response to the Centers for Medicare & Medicaid Services addresses the likely harm of the proposed conversion factor on the solvency and stability of rheumatology practices. The comments also include recommendations on complex drug administration coding, inflation-adjusted drug rebates and extending telehealth flexibilities.
The virtual event on Sept. 18 will include a guided art project, refreshments and a featured guest. All contributions will support pro-rheumatology lawmakers.
Approaching a critical Federal Election Commission reporting deadline on July 15, RheumPAC is just $976 short of its key mid-year fundraising goal.